Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors
February 14 2017 - 8:00AM
Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of
Alphatec Spine, Inc., a provider of spinal fusion technologies,
announced today that its board of directors has appointed David H.
Mowry as a member of the board of directors effective February 8,
2017. Mr. Mowry will be replacing Siri S. Marshall who
notified the Company that she was resigning from the Board,
effective as of February 8, 2017. Mr. Mowry is qualified as
an independent director under the definition established by Nasdaq.
Mr. Mowry is President and Chief Executive Officer
of Vyaire Medical, recognized global leader in the respiratory
diagnostics, ventilation, and anesthesia delivery and patient
monitoring market segments. Prior to Vyaire Medical, Mr. Mowry held
senior leadership positions within orthopedics, spine and medical
device industries, including Chief Operating Officer at Wright
Medical until 2016 and President and Chief Executive Officer of
Tornier from 2013 to 2015. Within the spine industry,
Mr. Mowry served as Vice President of Operations and Logistics
at Zimmer Spine. Mr. Mowry intends on limiting his board
participation to Alphatec (outside of Vyaire) in order to fully
engage with Alphatec and remain focused on helping the Company
pursue its goals.
“Dave brings a wealth of proven business and leadership
experience within the orthopedic and spine industries,” said Terry
Rich, Chief Executive Officer of Alphatec Spine. “Dave has been a
key mentor in my career and I am excited to work with him
again. His decision to join the board demonstrates confidence
in our vision and ability to build a high-growth U.S. spine company
through innovation and value creation. We look forward to his
counsel and benefitting from his impressive background and
expertise.”
Dave H. Mowry commented, “Alphatec is at a pivotal point in its
evolution with a strong portfolio of spinal fusion products, its
focus on the U.S. market and its new, spine-experienced leadership
team. I have had the pleasure of working with Terry and
several of his new commercial leaders in the past. We share a
common approach for delivering results and I am excited about being
engaged with him and his team. I look forward to contributing
to the achievement of their strategic goals and supporting
Alphatec’s future growth.”
Mr. Mowry, age 54, has served as President and Chief Executive
Officer of Vyaire Medical since May 2016. From October 2015 to May
2016 he served as Executive Vice President and Chief Operating
Officer and member of the board of directors of Wright Medical
Group N.V. (Nasdaq:WMGI). Between September 2015 and November 2016
he was a member of the board of directors of EndoChoice Holdings,
Inc. Prior to Wright Medical, Mr. Mowry served as President and
Chief Executive Officer and member of the board of directors of
Tornier N.V. from February 2013 until completing the merger with
Wright Medical in October 2015 and as Chief Operating Officer of
Tornier from 2011 to 2013. Prior to this, Mr. Mowry held executive
leadership positions at Covidien, ev3, and Zimmer Spine. Mr.
Mowry receive a B.S. in Engineering from the United States Military
Academy at West Point.
Further information regarding the Company’s appointment of David
H. Mowry to its board of directors is set forth in a Current Report
on Form 8-K that was filed with the U.S. Securities and Exchange
Commission (SEC) on February 14, 2017 and is available on both the
SEC’s website at www.sec.gov and the Company’s website at
www.alphatecspine.com.
About Alphatec Spine
Alphatec Spine, Inc., a wholly owned subsidiary
of Alphatec Holdings, Inc., is a global medical device company that
designs, develops and markets spinal fusion technology products and
solutions for the treatment of spinal disorders associated with
disease and degeneration, congenital deformities and trauma. The
Company's mission is to improve lives by delivering advancements in
spinal fusion technologies. The Company and its affiliates market
products in the U.S. via a direct sales force and independent
distributors.
Additional information can be found at
www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainty. Such statements are
based on management's current expectations and are subject to a
number of risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. Alphatec Spine cautions investors that there can be no
assurance that actual results or business conditions will not
differ materially from those projected or suggested in such
forward-looking statements as a result of various factors.
Forward-looking statements include the Company's ability to build a
high-growth U.S. spine company through innovation and value
creation and the Company’s ability to achieve its strategic
goals. The words "believe," "will," "should," "expect,"
"intend," "estimate" and "anticipate," variations of such words and
similar expressions identify forward-looking statements, but their
absence does not mean that a statement is not a forward-looking
statement. Please refer to the risks detailed from time to
time in Alphatec Spine's SEC reports, including its Annual Report
Form 10-K, as well as other filings on Form 10-Q and periodic
filings on Form 8-K. Alphatec Spine disclaims any intention
or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events, or
otherwise, unless required by law.
CONTACT: Investor/Media Contact:
Christine Zedelmayer
Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
czedelmayer@alphatecspine.com
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alphatec (NASDAQ:ATEC)
Historical Stock Chart
From Sep 2023 to Sep 2024